Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Apr 3, 2018 (9 years ago)

Capecitabine 500 mg Tablet NDC 00378-2512-78 28 days supply and…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Processing Controls.

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Capecitabine 500 mg Tablet NDC 00378-2512-78 28 days supply and 21 days supply

Affected NDC 0378-2512-78

Compare with the code on your package — it is the most precise check available.

Drug: Capecitabine

Recalling firm
Kroger Specialty Pharmacy, Inc.
NDC code
00378-2512-78
Origin
MS, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0791-2018 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Capecitabine recalls

See all
Class II · Moderate risk

Capecitabine Tablets

Failed Dissolution Specifications: low out-of-specification (OOS) results for dissolution were obtained at the nine-month stability point.

Terminated Dissolution failure Mylan Pharmaceuticals Inc NDC 0378-2512-78 D-1217-2015
Class II · Moderate risk

Capecitabine active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-559-2015

Other recalls by Kroger Specialty Pharmacy, Inc.

All 2018 recalls